These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
376 related items for PubMed ID: 27383246
41. Patient outcomes following an intervention involving community pharmacists in the management of depression. Crockett J, Taylor S, Grabham A, Stanford P. Aust J Rural Health; 2006 Dec; 14(6):263-9. PubMed ID: 17121506 [Abstract] [Full Text] [Related]
43. What impact does medicines shortages have on patients? A qualitative study exploring patients' experience and views of healthcare professionals. Atif M, Sehar A, Malik I, Mushtaq I, Ahmad N, Babar ZU. BMC Health Serv Res; 2021 Aug 17; 21(1):827. PubMed ID: 34404420 [Abstract] [Full Text] [Related]
44. Building capacity to implement cognitive pharmaceutical services: Quantifying the needs of community pharmacies. Feletto E, Wilson LK, Roberts AS, Benrimoj SI. Res Social Adm Pharm; 2010 Sep 17; 6(3):163-73. PubMed ID: 20813330 [Abstract] [Full Text] [Related]
45. Describing interruptions, multi-tasking and task-switching in community pharmacy: a qualitative study in England. Lea VM, Corlett SA, Rodgers RM. Int J Clin Pharm; 2015 Dec 17; 37(6):1086-94. PubMed ID: 26173938 [Abstract] [Full Text] [Related]
49. Community pharmacists' perceptions and experiences of medicine shortages in disruptive situations: a qualitative study. Bachoolall R, Suleman F. Int J Clin Pharm; 2024 Sep 13. PubMed ID: 39269641 [Abstract] [Full Text] [Related]
52. Implementing an integrated care management program in community pharmacies: A focus on medication management services. Smith MG, Ferreri SP, Brown P, Wines K, Shea CM, Pfeiffenberger TM. J Am Pharm Assoc (2003); 2017 Sep 13; 57(2):229-235.e1. PubMed ID: 28173993 [Abstract] [Full Text] [Related]
54. How do Australian metropolitan and rural pharmacists counsel consumers with prescriptions? Puspitasari HP, Aslani P, Krass I. Pharm World Sci; 2009 Jun 13; 31(3):394-405. PubMed ID: 19259780 [Abstract] [Full Text] [Related]
55. Challenges faced with opioid prescriptions in the community setting - Australian pharmacists' perspectives. Makdessi CJ, Day C, Chaar BB. Res Social Adm Pharm; 2019 Aug 13; 15(8):966-973. PubMed ID: 30819418 [Abstract] [Full Text] [Related]
56. Can a pharmacy intervention improve the metabolic risks of mental health patients? Evaluation of a novel collaborative service. Maulavizada H, Emmerton L, Hattingh HL. BMC Health Serv Res; 2016 Apr 26; 16():146. PubMed ID: 27112344 [Abstract] [Full Text] [Related]
58. Nurse practitioners: an insight into their integration into Australian community pharmacies. McMillan SS, Emmerton L. Res Social Adm Pharm; 2013 Apr 26; 9(6):975-80. PubMed ID: 23062783 [Abstract] [Full Text] [Related]
59. Knowledge that people with intellectual disabilities have of their inhaled asthma medications: messages for pharmacists. Davis SR, Durvasula S, Merhi D, Young PM, Traini D, Bosnic Anticevich SZ. Int J Clin Pharm; 2016 Feb 26; 38(1):135-43. PubMed ID: 26560115 [Abstract] [Full Text] [Related]
60. Describing the role of Australian community pharmacists in oral healthcare. Taing MW, Ford PJ, Gartner CE, Freeman CR. Int J Pharm Pract; 2016 Aug 26; 24(4):237-46. PubMed ID: 26809378 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]